Greenfern Industries (NZSE:GFI) - Stock Price, News & Analysis

GFI Stock Overview

Operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand.

GFI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NZ$3M)

Highly volatile share price over the past 3 months compared to the NZ market

Shareholders have been diluted in the past year

Greenfern Industries Limited Competitors

Rua Bioscience

NZSE:RUA

NZ$5.1m

BLIS Technologies

NZSE:BLT

NZ$23.0m

Cannasouth

NZSE:CBD

NZ$32.4m

AFT Pharmaceuticals

NZSE:AFT

NZ$272.7m

Price History & Performance

Summary of all time highs, changes and price drops for Greenfern Industries
Historical stock prices
Current Share Price	NZ$0.023
52 Week High	NZ$0.063
52 Week Low	NZ$0.015
Beta	0
11 Month Change	-11.54%
3 Month Change	9.52%
1 Year Change	-45.24%
33 Year Change	-91.64%
5 Year Change	n/a
Change since IPO	-94.46%

Recent updates

Shareholder Returns

	GFI	NZ Pharmaceuticals	NZ Market
7D	15.0%	13.9%	1.3%
1Y	-45.2%	62.5%	10.2%

Return vs Industry: GFI underperformed the NZ Pharmaceuticals industry which returned 61.4% over the past year.

Return vs Market: GFI underperformed the NZ Market which returned 10% over the past year.

Price Volatility

Is GFI's price volatile compared to industry and market?
GFI volatility
GFI Average Weekly Movement	14.8%
Pharmaceuticals Industry Average Movement	11.9%
Market Average Movement	4.5%
10% most volatile stocks in NZ Market	10.1%
10% least volatile stocks in NZ Market	3.1%

Stable Share Price: GFI's share price has been volatile over the past 3 months compared to the NZ market.

Volatility Over Time: GFI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of NZ stocks.

About the Company

Founded	Employees	CEO	Website
2018	n/a	Elizabeth Plant	gfi.nz

Greenfern Industries Limited operates as an entrepreneurial led licensed medicinal cannabis research and biotechnology company in New Zealand. It operates in the medicinal cannabis, industrial hemp, hemp food, and body care spaces. The company was incorporated in 2018 and is headquartered in Auckland, New Zealand.

Greenfern Industries Limited Fundamentals Summary

How do Greenfern Industries's earnings and revenue compare to its market cap?
GFI fundamental statistics
Market cap	NZ$2.63m
Earnings (TTM)	NZ$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is GFI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GFI income statement (TTM)
Revenue	NZ$0
Cost of Revenue	NZ$0
Gross Profit	NZ$0
Other Expenses	NZ$0
Earnings	NZ$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GFI perform over the long term?

See historical performance and comparison

Greenfern Industries NZSE:GFI Stock Report